HERC3 regulates epithelial-mesenchymal transition by directly ubiquitination degradation EIF5A2 and inhibits metastasis of colorectal cancer

被引：0
作者：
Zhiyuan Zhang
Guodong He
Yang Lv
Yu Liu
Zhengchuan Niu
Qingyang Feng
Ronggui Hu
Jianmin Xu
机构：
[1] Zhongshan Hospital,Department of General Surgery
[2] Fudan University,undefined
[3] State Key Laboratory of Molecular Biology,undefined
[4] Shanghai Institute of Biochemistry and Cell Biology,undefined
[5] Center for Excellence in Molecular Cell Science,undefined
[6] Chinese Academy of Sciences,undefined
来源：
Cell Death & Disease | / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
E3 ligase is widely reported to exert fundamental functions in cancers. Through rigorous bioinformatic analysis concentrating E3 ligases based on data from Genotype-Tissue Expression (GTEx) and data from The Cancer Genome Atlas (TCGA), HERC3 was indicated to be downregulated in colorectal cancer (CRC) and HERC3 downregulation showed poor overall survival (OS) and disease-free survival (DFS). Through qRT-PCR, western blotting and Immunohistochemistry (IHC), analytical results were validated based on tissues in Zhongshan hospital. Functionally, HERC3 was indicated to inhibit the migration, invasion and metastasis in vitro and in vivo through transwell assays, wound healing assays and vivo experiments. And HERC3 could regulate epithelial-mesenchymal transition (EMT) in CRC. Furthermore, immunoprecipitation (IP), coimmunoprecipitation (co-IP) and GST-pulldown assays indicated that HERC3 could directly interact with EIF5A2 in vitro and in vivo through the RCC1 domain in HERC3. And HERC3 could function as an E3 to promote the K27 and K48-linked ubiquitination degradation of EIF5A2 via the HECT domain in HERC3, besides, K47, K67, K85, and K121 in EIF5A2 were identified as ubiquitination sites. In addition, HERC3 was indicated to affect the migration, invasion and metastasis and further regulatE EMT via EIF5A2/TGF-/Smad2/3 signal. The present study may provide insight into the mechanism of EMT in CRC.
引用
收藏
相关论文
共 155 条
  • [1] Siegel RL(2020)Colorectal cancer statistics, 2020 CA: a Cancer J Clin 70 145-64
  • [2] Miller KD(2008)FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation Nat Rev Cancer 8 83-93
  • [3] Goding Sauer A(2005)The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase Cancer Cell 8 25-33
  • [4] Fedewa SA(2004)Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7 EMBO J 23 2116-25
  • [5] Butterly LF(2004)Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development J Biol Chem 279 9417-23
  • [6] Anderson JC(2008)FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression Sci (N. Y, NY) 321 1499-502
  • [7] Welcker M(2014)Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants Cell Rep. 6 657-69
  • [8] Clurman BE(2014)Landscape of genomic alterations in cervical carcinomas Nature 506 371-5
  • [9] Wei W(2013)High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma Gynecol Oncol 128 327-34
  • [10] Jin J(2007)FBXW7/hCDC4 is a general tumor suppressor in human cancer Cancer Res 67 9006-12
12345678910